A cadre of industry experts helping advance wireless health
Comprised of influential leaders in health care, wireless and mobile health, the Qualcomm Life Advisory Council (QLAC) is providing valued feedback to Qualcomm Life’s current and future offerings
Nancy Brown, American Heart Association
Benjamin Chu, MD, MPH, MACP, Kaiser Permanente
John Driscoll, CareCentrix
Kieran Gallahue, CareFusion
Arthur L Gruen, MD, EA Health
Matthew Holt, Health 2.0
James Hummer, Luxemburg Capital
Don Jones, Trial Fusion
Dean Kamen, DEKA Research & Development Corporation
Isaac Kohane, MD, Harvard Medical School
Daniel Kraft, MD, Exponential Medicine
Joseph Kvedar, MD, Partners HealthCare
Larry Leisure, Chicago Pacific Founders, Kleiner Perkins Caufield & Byers
Greg Lucier, NuVasive
Dana George Mead, Jr., Kleiner Perkins Caufield & Byers
Ed Michael, LionBird Ventures
Arnie Milstein, MD, Pacific Business Group on Health; Mercer Benefits Consulting; Stanford CERC
Diego Miralles, M.D., Johnson & Johnson Innovation
Rick Ratliff, Accenture
Lee Shapiro, 7wire Ventures
Lisa Suennen, Cardeation Capital, Venture Valkyrie Consulting
Eric Topol, MD, Scripps Translational Science Institute
Chris Wasden, Ed.D, MBA, Sorenson Center for Discovery and Innovation, University of Utah
Immediate-Past Chairman, Member Executive Committee and Board, National Health Council
Member, Board of Directors, Coalition to Transform Advanced Care
Member, Board of Directors and Executive Committee, Research! America
Member, Board of Directors, Alliance for a Healthier Generation
Member, Board of Directors, Campaign for Tobacco Free Kids
Member, Board of Directors, American Legacy Foundation
Member, Qualcomm Life Advisory Board
Member, FasterCures Research Acceleration and Innovation Network Advisory Council
Member, Board of Directors, Valentin Fuster-Mount Sinai Foundation for Science, Health and Empowerment
Member, Healthcare Advisory Board to the Bipartisan Policy Center’s CEO Council on Health and Innovation
Nancy Brown has been Chief Executive Officer of the American Heart Association (AHA) since 2009. The Association is widely known and highly respected as the world’s largest voluntary health organization dedicated to preventing, treating and defeating cardiovascular diseases and stroke.
During her tenure as CEO, the AHA has become a global leader in the discovery and dissemination of heart disease and stroke science. Notably, under Nancy’s leadership the Association announced its bold new 2020 health impact goal: To improve the cardiovascular health of all Americans by 20 percent while reducing deaths from cardiovascular diseases and stroke by 20 percent. Nancy’s drive to set a brave long-term goal, at a time when many other organizations were focused on short-term needs, has provided a rallying point for the Association’s millions of volunteers, staff, and donors.
Nancy has also led the organization to a number of significant advances in the time that she has served as its top staff executive, these include: a laser focus on prevention and improving cardiovascular health, instilling a culture of innovation spearheaded by the AHA’s Innovation Think Tank which has developed a number of critical new mission-aligned and revenue business enterprises for the Association, creating the AHA’s CEO Roundtable, comprised of CEOs of many of the largest and most influential corporations in America focused on innovating new solutions for health in the workplace, spearheading the Cardiovascular Genome-Phenome Study – a ground-breaking research enterprise focused on fulfilling the promise of precision medicine, developing the first-ever integrated global strategy for the Association, and launching new revenue strategies to expand individual giving/ major gifts and increase the Association’s revenue and mission impact in new and innovative ways.
In addition to her tireless efforts for the AHA, Nancy shares her passion for improving the health of individuals in the U.S. and globally by serving as Immediate-Past Chairman of the Board of the National Health Council. She also serves as a member of the Executive Committee of the National Health Council, Research!America, and on the Boards of Directors of the Coalition to Transform Advanced Care, the Campaign for Tobacco Free Kids, the Alliance for a Healthier Generation, the American Legacy Foundation, and the Valentin Fuster-Mount Sinai Foundation for Science, Health and Empowerment. Additionally, Nancy serves as a member of the Qualcomm Life Advisory Board, the FasterCures Research Acceleration and Innovation Advisory Council, the Healthcare Advisory Board to the Bipartisan Policy Center’s CEO Council on Health and Innovation, and Leadership18.
Prior to being named CEO, Nancy served as AHA's Chief Operating Officer for the eight prior years. In this role she managed the Association's mission, science and operations functions and led the AHA's integrated strategy to achieve its 2010 Impact Goal to reduce coronary heart disease, stroke and risk by 25 percent. Notable accomplishments include the creation of the AHA’s signature platform Go Red for Women, creation of a suite of quality improvement programs including Get with the Guidelines, and notable advances in science, research, and consumer health and engagement. She has held multiple leadership positions at the AHA since her start in 1986 leading fundraising initiatives in the Michigan Affiliate, including serving as the Executive Director in Metro Detroit, as well as leading the AHA’s work as Executive Vice President of the former Massachusetts and former New England Affiliates. Prior to joining the American Heart Association, Nancy also served her home state of Michigan as Director of Development/ Deputy Director of the Endowment Campaign for the Michigan Cancer Foundation, and as Special Events Director for Mount Carmel Mercy Hospital in Detroit.back to top
Benjamin Chu, MD, MPH, MACPExecutive Vice President Group President, Southern California and Georgia President, Southern California Region Kaiser Permanente
Benjamin K. Chu, MD, MPH, MACP, was named group president for Kaiser Permanente’s Southern California and Georgia Regions in October 2014. He directs health plan and hospital operations for 14 hospitals and 237 medical offices to serve more than 4 million members in both locations.
Dr. Chu joined Kaiser Permanente as its regional president of Southern California in February 2005. In January 2011, he was given the added responsibility of overseeing the Hawaii region as a group president responsible for both the Southern California and Hawaii regions. In July 2013, he was named executive vice president for Kaiser Foundation Hospitals and Kaiser Foundation Health Plan Inc. and appointed to the National Executive Team, which supports the chairman and CEO in setting and ensuring achievement of both the short- and long-term strategies and performance of the Hospitals and Health Plan organizations.
Before coming to Kaiser Permanente, Dr. Chu served for three years as president of New York City’s Health and Hospitals Corporation (HHC), the largest public hospital system in the country. A primary care internist by training, Dr. Chu possesses extensive health care experience as a clinician, administrator, and policy advocate. He was senior vice president for Medical and Professional Affairs for HHC in New York from 1990 to 1994. During that period, he also served as acting commissioner of Health for the New York City Department of Health.
Dr. Chu also has experience as an academic health center leader. He was senior associate dean at Columbia University College of Physicians and Surgeons from July 2000 – February 2002. He also served at the New York University School of Medicine and Medical Center as associate dean and vice president for Clinical Affairs from April 1994 – May 2000. He was a 1989-1990 Robert Wood Johnson Policy Fellow serving as legislative assistant for health for New Jersey Senator Bill Bradley.
At both Kaiser Permanente and New York City, Dr. Chu has been a strong proponent of the use of the electronic health record as a powerful tool for improving quality and outcomes for patient care.
Dr. Chu currently serves as chair of the board of directors for the Commonwealth Fund in New York and is a member of the Advisory Committee to the director, Centers for Disease Control and Prevention. He is a past chair of the American Hospital Association Board of Trustees.
Dr. Chu earned his medical degree at New York University, his master’s degree in public health from Columbia University, and a bachelor’s degree in psychology from Yale University.back to top
John DriscollCEO, CareCentrix
John Driscoll brings more than 25 years of health care experience to CareCentrix as CEO. Prior to CareCentrix, John served as president at Castlight Health, a healthcare technology company. Previously John served as group president for new markets at Medco and led product development for Medco’s employer and health plan clients. Mr. Driscoll was responsible for corporate development and led Medco’s entry into Medicare, international markets and pharma services.
Mr. Driscoll founded and chaired the Surescripts ePrescribing Network. He also served as an advisor to Oak Investment Partners, and held a number of senior operating positions at Oxford Health Plans, including corporate vice president for government programs.
John has a B.A. and M.B.A. from Harvard University as well as an M.Phil from Cambridge University in England. John is the chairman of the Truman National Security Project and is an advisory board member of Bread for the World.back to top
Kieran GallahueChairman and CEO, CareFusion
Kieran Gallahue is the former Chairman and CEO of CareFusion, Inc, a publicly traded medical technology firm focused on improving the safety and lowering the cost of healthcare for providers on a global basis. CareFusion was acquired by Becton Dickinson in 2015 for over $12 billion. Prior to CareFusion, Kieran was CEO of ResMed, Inc. ResMed is a publicly traded medical technology firm focused on the identification and treatment of sleep apnea and other breathing related disorders. Prior to this role, Kieran held numerous positions at ResMed, Nanogen, Instrumentation Laboratory, P&G and GE. He was a director for Volcano, Inc, until its sale to Philips, and is currently a director for Edwards Lifesciences and Intersect ENT. Kieran was formally a member of the executive committee for AdvaMed, the association representing over 85% of medical technology company revenues in the United States.back to top
Arthur L Gruen, MDCEO, EA Health
Arthur L Gruen, MD is CEO of EA Health, with 23 years experience in developing physician service organizations with comprehensive administrative support platforms and revenue cycle systems to promote on-call and multi-specialty physician availability for hospital Trauma Centers and Emergency Departments. EA Health has transformed over time into a full spectrum revenue cycle management services enterprise focused on getting physicians paid fairly across all healthcare settings, including telemedicine.
Dr. Gruen received his undergraduate degree from Harvard University and medical degree from Albert Einstein College of Medicine. Dr. Gruen completed his physician clinical training in emergency medicine at Los Angeles County-USC Medical Center. Dr. Gruen is the 2012 winner of the Ernst & Young Entrepreneur of the Year award.
For the past 23 years, Dr. Gruen has served as the Executive Medical Director of Emergency Services at Sharp Memorial Hospital in San Diego, the only Emergency Department in the world to offer life-saving cardiopulmonary support through Extra-Corporeal Membrane Oxygenation (ECMO). In addition, Sharp Memorial Hospital is the only acute care hospital in Southern California to have won the Presidential Malcolm Baldrige Award for excellence.
Dr. Gruen also proudly serves as the Executive Physician Advisor for AMN Healthcare, the nation’s largest healthcare staffing company.back to top
Matthew HoltBlogger/Founder, Health 2.0
Matthew Holt has been in health care for over 20 years as a researcher, generalist forecaster and strategist. He is known for his work with some of the best forecasting and survey research organizations in the US including the Institute for the Future and Harris Interactive. He has conducted in-depth studies about many aspects of health care for public release and private clients. He is a well-regarded and amusing presenter and has delivered several keynote addresses. These days, Matt is best known for two things: being the founder (and now occasional) author of The Health Care Blog, which is one of the best-read blogs in health care. His day job is the co-chairman (with Indu Subaiya) of Health 2.0, the leading venue for innovative technology in health care. Health 2.0 has a large annual conference in the U.S. with other franchise conferences across the U.S. and abroad. It also offers a market intelligence and advisory service, its own media and TV channel, a platform for prize challenges and a large community of followers with chapters in more than 30 cities worldwide.back to top
James HummerFounder, Luxemburg Capital
James Hummer founded and ran Whole Health Management for 21 years. He was one of the first to see the opportunity in helping self-insured employers bring their health care services "into the tent." Whole Health originated as an on-site health provider to the federal sector. James started the business in 1987, purchased a competitor in the late 1980s. By the time he sold the company to Walgreens in March 2008, he was running 70 clinics for private-sector employers, including Continental Airlines, Intel, Sprint and Qualcomm. Whole Health is now part of Walgreens' Premise Health unit. Previously, James founded Ivy Medical Group, a large ambulatory care practice. He serves as Chairman of the Board for Endotronix and is an investors and advisor to several health care companies, including Healthspot and MDLive. Named regional Ernst & Young Entrepreneur of The Year in 2008, James now invests in health care startups through Luxemburg Capital and Redrock Ventures.back to top
Don JonesCEO, Trial Fusion
Donald Jones is a globally recognized leader in Digital Medicine (sometimes referred to as Wireless Health, Digital Health, Connected Health, or mHealth). He is sought out as a speaker, advisor and board member. He works with healthcare, pharmaceutical and medical device, OEM, Telcos and early stage companies. Donald Jones is the CEO of Trial Fusion, a company focused on commercializing digital health products by providing design and partnership expert advise and clinical, user experience and economic evidence required for their adoption. Jones also serves as the Chief Digital Officer of the Scripps Translational Science Institute, working with the renowned Eric Topol, MD, on the convergence of genomics and wireless health – digital medicine. He co-founded Scripps Digital Medicine, the world’s first clinical trial center focused on digital health and large data sets. For 11 years through 2014, he led Wireless Health Global Strategy and Business Development for Qualcomm. He is Founder and Chairman of the Wireless Life Sciences Alliance. Working with the XPRIZE Foundation and Qualcomm’s CEO, Jones conceived the $10 million Qualcomm Tricorder XPRIZE, a global competition for a consumer device which makes medical diagnoses. CommNexus recognized Donald Jones as 2014 Digital Health Innovator of the Year.back to top
Dean KamenInventor and Founder, DEKA Research and Development Corporation
Dean Kamen is an inventor, entrepreneur and tireless advocate for science and technology. His roles as inventor and advocate are intertwined—his own passion for technology and its practical uses has driven his personal determination to spread the word about technology's virtues and by so doing to change the culture of the U.S. As an inventor, he holds more than 440 U.S. and foreign patents, many of them for innovative medical devices that have expanded the frontiers of health care worldwide. While still a college undergraduate, he invented the first wearable infusion pump, which rapidly gained acceptance from such diverse medical specialties as chemotherapy, neonatology and endocrinology. In 1976, he founded his first medical device company, AutoSyringe, Inc., to manufacture and market the pumps. At age 30, he sold that company to Baxter Healthcare Corporation. By then, he had added a number of other infusion devices, including the first wearable insulin pump for diabetics. Following the sale of AutoSyringe, Inc., he founded DEKA Research and Development Corporation to develop internally generated inventions as well as to provide research and development for major corporate clients. Kamen led DEKA's development of the HomeChoice™ peritoneal dialysis system for Baxter International Inc. The HomeChoice system allows patients to be dialyzed in the privacy and comfort of their home and quickly became the worldwide market leader. Dean also led the development of technology to improve slide preparation for the CYTYC (now Hologic Inc.) ThinPrep® Pap Test. Kamen-led DEKA teams have also developed critical components of the UVAR™ XTS™ System, an extracorporeal photophereisis device marketed by Therakos, a unit of Johnson & Johnson, for treatment of T-cell lymphoma. An advanced prosthetic arm in development for DARPA should advance the quality of life for returning injured soldiers. Other notable developments include the Hydroflex™ surgical irrigation pump for C.R. Bard, the Crown™ stent, an improvement to the original Palmaz-Schatz stent, for Johnson & Johnson, the iBOT™ mobility device, and the Segway® Human Transporter. Dean has received many awards for his efforts. Notably, he was awarded the National Medal of Technology in 2000. Presented by President Clinton, this award recognizes inventions that have advanced medical care worldwide, and for innovative and imaginative leadership in awakening America to the excitement of science and technology. Dean was also awarded the Lemelson-MIT Prize in 2002, and was inducted into the National Inventors Hall of Fame in May 2005. In addition to DEKA, one of Dean's proudest accomplishments is founding FIRST® (For Inspiration and Recognition of Science and Technology), an organization dedicated to motivating the next generation to understand, use and enjoy science and technology. Founded in 1989, this year FIRST will serve more than 250,000 young people, ages 6 to 18, in more than 50 countries around the globe. High school-aged participants are eligible to apply for more than $14 million in scholarships from leading colleges, universities and corporations. Studies have shown that FIRST alumni are highly motivated to pursue careers in science and engineering, thus fulfilling Dean's goal of inspiring the next generation of technological leaders.back to top
Isaac Kohane, MDDirector of the Children's Hospital Informatics Program; Henderson Professor of Pediatrics and Health Sciences and Technology, Harvard Medical School
Isaac (Zak) Kohane, MD, is the director of the Children's Hospital Informatics Program and is the Henderson Professor of Pediatrics and Health Sciences and Technology at Harvard Medical School (HMS). He is also co-director of the HMS Center for Biomedical Informatics and Director of the HMS Countway Library of Medicine. Dr. Kohane leads multiple collaborations at Harvard Medical School and its hospital affiliates in the use of genomics and computer science to study cancer and the development of the brain, with an emphasis on autism. He has developed several computer systems to allow multiple hospital systems to be used as "living laboratories" to study the genetic basis of disease, while preserving patient privacy. Dr. Kohane's research builds on his doctoral work in computer science on decision-support and subsequent research in machine-learning applied to biomedicine. Dr. Kohane has led the development of cryptographic health identification systems, automated personal health records and peer-to-peer pathology information networks. Dr. Kohane leads several NIH-funded efforts to translate genomic research into clinical practice and continues his own practice in pediatric endocrinology at Children's Hospital Boston.back to top
Daniel Kraft, MDChair, Singularity University & Executive Director, Exponential Medicine
Daniel Kraft, MD, is a Stanford and Harvard-trained physician-scientist, inventor, entrepreneur and innovator. Dr. Kraft has over 20 years of experience in clinical practice, biomedical research and healthcare innovation. Daniel chairs the Medicine track for Singularity University and is executive director for Exponential Medicine, a program that explores convergent, exponentially developing technologies and their potential in biomedicine and healthcare. Following his undergraduate degree at Brown and medical school at Stanford, Dr. Kraft was board certified in the Harvard combined internal medicine and pediatrics residency program at Massachusetts General Hospital and Children’s Hospital Boston. He went on to complete Stanford fellowships in hematology/ oncology and bone marrow transplantation, and extensive research in stem cell biology and regenerative medicine. He has multiple scientific publications (including in Nature and Science) and medical device, immunology and stem cell-related patents through faculty positions with Stanford University School of Medicine and as clinical faculty for the pediatric bone marrow transplantation service at UCSF. Dr. Kraft recently founded IntelliMedicine, focused on enabling connected, data-driven and integrated personalized medicine. He is also the inventor of the MarrowMiner, an FDA-approved device for the minimally invasive harvesting of bone marrow, and founded RegenMed Systems, a company developing technologies to enable adult stem cell-based regenerative therapies. Daniel is an avid pilot and has served in the California Air National Guard as an officer and flight surgeon with an F-16 fighter squadron. He has conducted research on aerospace medicine that was published with NASA, with whom he was a finalist for astronaut selection.
Joseph Kvedar, MDFounder and Director, Center for Connected Health, Partners HealthCare
Joseph Kvedar, MD, is the founder and director of the Center for Connected Health at Partners Healthcare, which works to create a new model of health care delivery by developing programs and innovative strategies to move care from the hospital or doctor’s office into the day-to-day lives of patients. In his role with the Center for Connected Health, Dr. Kvedar is creating innovative programs to leverage information technology—cell phones, computers, networked devices and simple remote health monitoring tools—to help providers and patients manage chronic conditions, maintain health and wellness and improve adherence, engagement and clinical outcomes. Based on the technology platform developed at the Center, Healthrageous, a personalized health technology company, was launched in 2010, offering a range of health and wellness self-management programs to its clients. In addition, Dr. Kvedar also launched the first physician-to-physician online consultation service in an academic setting, which today electronically links patients from around the world and their local providers with leading specialists at Harvard-affiliated teaching hospitals. Dr. Kvedar is internationally recognized for his leadership and vision in the field of connected health and the application of communications technologies to improve health care for patients. He is a frequent lecturer and has authored over 70 publications on the subject. Dr. Kvedar serves as a board member for a number of organizations, including the Continua Health Alliance and the Care Continuum Alliance. He also is a co-founder of Healthrageous and chair of the company’s Scientific Advisory Board. Dr. Kvedar is a past president and board member of the American Telemedicine Association (ATA) and a past chair of the American Academy of Dermatology (AAD) Task Force on Telemedicine. In 2009, Dr. Kvedar was honored by the ATA with its Individual Leadership Award, recognizing his significant contributions to connected health and telemedicine. Mass High Tech, the Journal of New England Technology named Dr. Kvedar an All-Star in the field of health care and he has been honored by the New England Business and Technology Association for his extraordinary leadership in the field. A division of Partners HealthCare, the Center for Connected Health works with Harvard Medical School-affiliated teaching hospitals, including Massachusetts General Hospital and Brigham and Women’s Hospital. Dr. Kvedar is also a board-certified dermatologist and associate professor of dermatology at Harvard Medical School.back to top
Larry LeisureCo Founder and Managing Director, Chicago Pacific Founders, Kleiner Perkins Caufield & Byers
Larry Leisure is a Co Founder and Managing Director of Chicago Pacific Founders, a Chicago and San Francisco private equity fund focused on senior living and care delivery services. In addition, he serves as Chairman of Washington, D.C. based ADVI that provides advisory services to the life sciences and managed care industries. Larry is also a Senior Advisor to the Silicon Valley venture capital firm, Kleiner Perkins Caufield & Byers.
Larry has had a distinguished career in health care, serving in venture capital, private equity, management consulting and industry operating roles. Organizations where he has held senior leadership positions include Accenture as Global Managing Partner for the Health Vertical; Price Waterhouse where he led their Employer and Payer Managed Care Practice; Towers Perrin where he led their Group Benefits and Managed Care practices; Kaiser Foundation Health Plans where he oversaw national sales & account management; and UnitedHealth Group where oversaw the Payer Segment for Ingenix Consulting (now Optum Health).
In 2009 Larry founded AccelusHealth Partners, LLC that merged with HillcoHealth to form ADVI in 2013. He also co-founded Healthspottr, a new media company focused on the acceleration of innovation in health care. He serves as a board member for several health related companies, including Accretive Health, Jiff, Lumiata, and Recovery Ways.
Larry received his AB in Economics from Stanford University and his MBA in Finance from the
University of California, Los Angeles.
Larry resides in Atherton, California with his wife Bren.back to top
Greg LucierChairman of the Board and CEO, NuVasive
Gregory T. Lucier has served as our Chairman and Chief Executive Officer since May 2015. He has served as a member of the NuVasive Board of Directors since December 2013. From May 2003 to February 2014, Mr. Lucier served as Chairman and Chief Executive Officer of Life Technologies, a global life sciences company acquired by Thermo Fisher Scientific in 2014. During Mr. Lucier’s 11-year tenure at Life Technologies, he led the company from a small start-up known as Invitrogen in 2003, directed the acquisition and merger of Invitrogen with Applied Biosystems in 2008 into the renamed Life Technologies, and then transformed the organization by 2013 into a global, world-leading biotechnology firm with 50,000 products, 12,000 employees and nearly $4 billion in sales in more than 180 countries. Serving in his leadership role, Mr. Lucier was responsible for fostering a culture of excellence and applied his more than 25 years of strategic management experience to deliver industry-leading operating margins, double-digit compounded annual growth in earnings per share and significant free cash flow. Mr. Lucier previously was a Corporate Officer of General Electric and served as an executive at GE Medical Systems. He received a bachelor’s degree in engineering from Pennsylvania State University and a masters of business administration from Harvard Business School. In addition to serving on the Board of NuVasive, Mr. Lucier serves on the Board of the Sanford Burnham Prebys Medical Discovery Institute and is a member of the Board of Directors for Catalent, Inc. and Invuity, Inc. Additionally, Mr. Lucier is a former director of CareFusion Corporation, now part of Becton, Dickinson & Co.back to top
Dana George Mead, Jr.Partner, Kleiner Perkins Caufield & Byers
Dana Mead joined Kleiner Perkins Caufield & Byers as a partner in May 2005 to work in the firm’s life sciences practice. He leverages experience accrued from his venture-funded, startup management roles and board participation to support entrepreneurs and innovators dedicated to making a real difference in the lives of millions suffering from life-limiting diseases. Dana serves on the boards of Apnicure, Awarepoint, Corventis, Inspire Medical Systems, Intersect ENT, Invuity, Pulmonx, Spiracur, Spinal Modulation, and Teladoc. For the past 29 years, Dana’s career has focused on identifying new medical technologies, developing new markets and therapies, and building world-class management teams. He has worked with physician thought leaders around the world representing 10 medical specialties. Before joining KPCB, Dana was president of Guidant Vascular Intervention, a fully integrated billion-dollar division with more than 4,500 employees. He joined Guidant in 1992 and held positions of increasing responsibility during his tenure, including vice president and general manager, Cardiac & Vascular Surgery; vice president and general manager, Stents, Vascular Intervention Group; president, Japan and A/P Operations based in Tokyo; and vice president, Corporate Relations and Policy, with responsibility for investor relations, corporate communications, corporate marketing and public policy initiatives. Earlier in his career, Dana worked in various sales and marketing roles at Allergan, Inc. and Johnson & Johnson. Dana formerly served as a director of the Cardiovascular Research Foundation, Aesthera (acquired by Solta [Nasdaq: SLTM]), OtisMed (acquired by Stryker [Nasdaq: SYK]) and Navigenics (acquired by Life Technologies [Nasdaq: LIFE]). He currently serves on the boards of the California Healthcare Institute and Lucile Packard Children’s Hospital at Stanford University, and he is the chair of the Lafayette College West Coast Advisory Council. A native of Connecticut, Dana received his B.A. degree from Lafayette College and holds an M.B.A from the University of Southern California.back to top
Ed MichaelFounder and Managing Partner, LionBird Ventures
Ed Michael is a founder and Managing Partner of LionBird Ventures (www.lionbird.com), a venture capital firm with offices in Tel Aviv and Chicago which focuses on early stage investments in the digital health, commerce and enterprise fields.
Ed started LionBird on 2012 immediately after his retirement from Abbott, where he worked for almost 27 years. For the last five years of his career at Abbott, Ed was Executive Vice President, Diagnostic Products, with overall responsibility for businesses generating $4 billion in annual revenues and employing over 13,000 people around the world. In that role, he successfully led efforts to radically transform the core diagnostics business and return it to growth and profitability, and to develop a digital health strategy for Abbott.
Ed is currently on the boards of NeuMoDx, an early stage molecular diagnostics company, as well as Ovuline, Telesofia, physIQ, AmSTATZ, and Staffly, all LionBird portfolio companies. He formerly served on the board of the Cook County Health and Hospitals System, one of the largest public health systems in the country.back to top
Arnie Milstein, MDMedical Director, Pacific Business Group on Health; Mercer Benefits Consulting; Stanford CERC
Arnie Milstein, MD is a professor of medicine at Stanford and directs the Stanford Clinical Excellence Research Center (CERC). The Center is a collaboration of the Schools of Medicine, Engineering and Business to design and test new health care delivery models that both lower per capita health care spending and improve clinical outcomes. His career and ongoing research is focused on the acceleration of clinical service innovations that improve the societal value of health care. He also serves as the medical director of the Pacific Business Group on Health (PBGH), the largest regional health care improvement coalition in the US. He also guides employer-sponsored, clinically based innovation development for Mercer Health and Benefits and chairs the Steering Committee that directs the largest US physician pay-for-performance program, operated by the Integrated Healthcare Association. Previously he co-founded the Leapfrog Group and Consumer-Purchaser Disclosure Project, and served as a Congressionally-appointed MedPAC Commissioner. Citing his nationally distinguished innovation in health care cost reduction and quality gains, he was selected for the highest annual award of the National Business Group on Health (NBGH) and of the American College of Medical Quality. Elected to the Institute of Medicine (IOM) of the National Academy of Sciences, he chaired the planning committee of its examination of best methods to lower per capita health care spending and improve clinical outcomes. He was educated at Harvard (BA in economics), Tufts (MD) and UC Berkeley (MPH in health services evaluation and planning).back to top
Diego Miralles, M.D.Head, Johnson & Johnson Innovation
Diego Miralles, M.D., is Head, Johnson & Johnson Innovation, with responsibility for the regional innovation centers located in California, Boston, London and Asia Pacific, as well as JLABS incubators.
Diego and his team are focused on accessing the most promising early stage external science and technology and developing collaborations across sectors between external innovators and the Johnson & Johnson Family of Companies.
Diego has led a number of key innovation initiatives throughout the global Johnson & Johnson organization. As founding member of Johnson & Johnson Innovation, Diego played a leading role in launching the innovation center in California, and founded the JLABS incubator for life science companies, a model that has been replicated in five locations across North America. Diego established and led Janssen Healthcare Innovation which successfully launched patient-centric Care4Today™ solutions across North America and Europe that have delivered improved outcomes for patients and consumers in areas such as medication adherence, mental health, cardiovascular health and surgical recovery.
Diego joined the healthcare industry more than 15 years ago after a dozen years in the hospital and academic worlds, including leading extensive clinical research, primarily focused on HIV/AIDS. Diego has extensive experience in clinical and basic research, including work on antiviral drug development at Tibotec, Trimeris, and Triangle Pharmaceuticals. He currently serves as an adjunct full professor in the Pharmacology Department at the University of California, San Diego (UCSD) and serves on the Board of the Rady Children’s Hospital of San Diego and the UCSD Health System. Diego served on the faculty and in clinical practice at Duke University, Durham, NC. He completed his fellowship in Infectious Diseases at Cornell University-New York Hospital following a residency in Internal Medicine at the Mayo Clinic in Rochester, MN. Diego is a graduate of the University of Buenos Aires School of Medicine.back to top
Rick RatliffManaging Director, Accenture
Rick is a Managing Director in Accenture’s Health & Public Service Practice. As the Lead for Digital Health, Rick is responsible for defining and executing Accenture’s strategy to enable healthcare clients to become digital businesses. Prior to his current role, Rick was the Global Lead for Connected Health Services where he created a practice of over 800 experts in healthcare interoperability that assisted clients around the world in leveraging technology to improve clinical integration and develop platforms for new care delivery models.
Before joining Accenture, Rick was the founding Chief Operating Officer for the largest electronic prescribing network in the United States, Surescripts and held various management positions at IBM, VHA and Healthvision. He is a board member of the eHealth Initiative in Washington, DC. Rick has worked with clients around the world in various sectors of healthcare including provider, payer, retail pharmacy, lab services, life sciences and government healthcare organizations.back to top
Lee ShapiroManaging Partner, 7wire Ventures
Lee Shapiro is currently a Managing Partner at 7wire Ventures, an investment firm he co-founded more than a decade ago. He is Executive Chairman of Zest Health, which is helping consumers better navigate their health options, and Chairman of the Board at Modern Teacher, a digital education innovator focused on transitioning schools from textbooks to technology. He also serves on the boards of Livongo Health, Medidata Solutions [NASDAQ:MDSO], Healthways [NASDAQ:HWAY], Physicians Interactive Holdings (a Merck subsidiary [NYSE:MRK]), Ayogo and Carebox.
Previously he was President of Allscripts [NASDAQ:MDRX] from 2001 until the end of 2012. His leadership was integral in the execution of over $4B in mergers, acquisitions and financings. His responsibilities included the company's strategy, international operations, business development and partnerships, government relations, health plan initiatives and business activities in the areas of analytics and information services. He also served as executive sponsor for Allscripts’ key strategic relationships with companies such as Microsoft, Dell, Fujitsu, Henry Schein, Xerox/ACS and Intuit.
Lee played a critical role in developing the network of alliances that were and will continue to be critical to the company's success - improving solutions, expanding offerings, enhancing market presence and broadening opportunities. At times during his tenure at Allscripts, he served as the company’s Chief Operating Officer leveraging his unique grasp of the business operations across the spectrum of development, sales, marketing, services and support.
Prior to joining Allscripts, Lee was the Chief Operating Officer of Douglas Elliman-Beitler, a premier commercial office management and development company, where he directed all business activities throughout the United States. Lee also previously served as president of SES Properties, Inc., a closely held, fully integrated real estate company and, at that time, the largest retail developer in Las Vegas, NV. Concurrently, Lee formed City Financial Bancorp and served as its Vice Chairman. He was responsible for acquisition of financial institutions, financing, regulatory issues, legal affairs, and restructuring of operations leading to the ultimate sale of this $100 million holding company.
He is a member of the Kellogg Innovation Network Advisory Board of the Kellogg School of Management, Northwestern University, the University of Chicago Innovation Fund Advisory Committee and the Qualcomm Life Advisory Council. Lee was appointed by Governor Quinn to the Illinois Economic Recovery Commission in 2009. He has also served as an officer and director of the Gastro-Intestinal Research Foundation (GIRF) where he now serves on the advisory board.
Lee practiced commercial law at Barack, Ferrazzano, Kirschbaum, Perlman and Nagelberg, a prominent Chicago law firm. He holds a JD degree from The University of Chicago Law School and a BS in Accounting from the University of Illinois.
A well-known international speaker at healthcare technology conferences, Mr. Shapiro has also seen his articles published in a variety of trade publications.
Lee and his wife, Valerie, have three wonderful grown children and reside in the Chicago area. Lee is an avid marathoner and sports fan.back to top
Lisa SuennenManaging Member, Cardeation Capital
Managing Partner, Venture Valkyrie Consulting
Lisa Suennen is Managing Member of Cardeation Capital, a venture fund sponsored by the American Heart Association.
She is also Managing Partner at Venture Valkyrie Consulting, which provides business advisory services to companies, venture capital firms and non-profit organizations in the healthcare field.
Lisa is a board member of Beyond Lucid Technologies and Humetrix, and the Dignity Health Foundation. She is an advisory board member at HealthXL, Qualcomm Life and the California Healthcare Foundation and advises several private companies. Lisa also writes Venture Valkyrie, a widely read blog on healthcare and investing and hosts the Tech Tonics podcast. She has recently published her first book: Tech Tonics, Can Passionate Entrepreneurs Heal Healthcare with Technology.
Previously Lisa spent 15 years with Psilos Group, a healthcare-focused venture capital firm where she was a co-founder and Partner. Earlier, Lisa helped build Merit Behavioral Care, an $800mm behavioral healthcare company where she held various senior executive roles over nine years from the company’s early start-up days through exit. Previously, Lisa held various positions in the high technology field.
Lisa holds undergraduate and graduate degrees from UC Berkeley, where she is now on faculty at the Haas School of Business.
back to top
Eric Topol, MDDirector, Scripps Translational Science Institute, Chief Academic Officer, Scripps Health, Professor of Genomics, The Scripps Research Institute, Senior Consultant, Cardiovascular Diseases, Scripps Clinic La Jolla, California
Eric Topol is a Professor of Genomics at the Scripps Research Institute, the Chief Academic Officer for Scripps Health, and the Director of the Scripps Translational Science Institute (STSI). Voted as the #1 Most Influential Physician Executive in the United States in a national poll conducted by Modern Healthcare, Dr. Topol works on genomic and wireless digital innovative technologies to reshape the future of medicine. He is a practicing cardiologist at Scripps in La Jolla, California and widely credited for leading the Cleveland Clinic to become the #1 center for heart care. While there he also started a new medical school, led many worldwide clinical trials to advance care for patients with heart disease, and spearheaded the discovery of multiple genes that increase susceptibility for heart attacks. Since 2006, in La Jolla, he leads the flagship NIH grant supported STSI. He has published 1100 peer-reviewed articles, over 165,000 citations, elected to the Institute of Medicine of the National Academy of Sciences, named in GQ Magazine as one of the Rock Stars of Science, and is one of the top 10 most cited researchers in medicine (Thomson Reuters, “Doctor of the Decade”). He is also Editor-in-Chief of Medscape. His bestseller book The Creative Destruction of Medicine (Basic Books) was published in 2012 and The Patient Will See You Now was just published in January 2015.back to top
Chris Wasden, Ed.D, MBAExecutive Director, Sorenson Center for Discovery and Innovation, University of Utah
Dr. Chris Wasden is the Executive Director of the Sorenson Center for Discovery and Innovation at the University of Utah. His book Tension: The Energy of Innovation describes how we can harness tension in our lives and organizations to fuel our creative genius. Previously he was a Managing Director at PwC and the Global Healthcare Innovation Leader. He is a named inventor on 11 issued patents and has been a leader in 10 different startups where he developed many of his ideas around the innovation cycle and lifecycle and how fast, frequent, frugal, and failure accelerates innovation. Dr. Wasden has a doctorate in human and organizational learning from George Washington University in Washington, DC, an MBA from the UCLA Anderson School, and bachelor degrees in accounting (BS) and Asian studies (BA) from Brigham Young University in Provo, Utah.back to top